Jeanette joined Noxopharm in 2019, with over 30 years’ experience in the private, public and corporate healthcare sectors. This included 15 years with Lilly Pharmaceuticals in positions spanning Clinical Research, Clinical Portfolio Management, Medical Affairs, Medical and Commercial Operations, Drug Development, Sales and Marketing settings and Launch Excellence Management. Through these diverse tenures, Jeanette developed a deep understanding on the mechanisms (and challenges) associated with progressing assets through the drug development pipeline to market.
The opportunity in the pharmaceutical industry to hold leadership positions across Australia, New Zealand, Europe, Asia Pacific (mid-size countries) China, and Japan - has afforded Jeanette deep insights into the intricate strategic frameworks required to deliver a strategic vision across multiple regions and stakeholder groups.
As Chief Operating Officer at Noxopharm, Jeanette is tasked to implement an operations framework to deliver the Clinical Development Plan. This includes creating processes for strategic planning and prioritization of projects, resourcing of projects, vendor management, and the implementation of systems and processes for Quality Assurance and Data Risk Management. Jeanette is also involved in Business Development activities for Noxopharm.
Jeanette holds Bachelor of Medical Science (BMedSc) and Master of Science Management (MScM) degrees and operations related qualifications in Portfolio Management (PMO) and Six Sigma Methodologies.